PubMed

Factors influencing lopinavir and atazanavir plasma concentration.

Stöhr W, Back D, Dunn D, Sabin C, Winston A, Gilson R, Pillay D, Hill T, Ainsworth J, Gazzard B, Leen C, Bansi L, Fisher M, Orkin C, Anderson J, Johnson M, Easterbrook P, Gibbons S, Khoo S; on behalf of the UK CHIC Steering Committee.

J Antimicrob Chemother. 2009 Nov 6. [Epub ahead of print]PMID: 19897506 [PubMed - as supplied by publisher]Related articles

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

Grant AD, Bansi L, Ainsworth J, Anderson J, Delpech V, Easterbrook P, Fisher M, Gazzard B, Gilson R, Gompels M, Hill T, Johnson M, Leen C, Orkin C, Phillips AN, Porter K, Post F, Walsh J, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group.

AIDS. 2009 Nov 27;23(18):2507-15.PMID: 19770622 [PubMed - in process]Related articles

Virological response to initial antiretroviral regimens containing abacavir or tenofovir.

Bansi L, Sabin C, Gilson R, Gazzard B, Leen C, Anderson J, Dunn D, Hill T, Fisher M, Ainsworth J, Pillay D, Johnson M, Walsh J, Orkin C, Easterbrook P, Gompels M, Phillips A; UK Collaborative HIV Cohort Study.

J Infect Dis. 2009 Sep 1;200(5):710-4.PMID: 19635022 [PubMed - indexed for MEDLINE]Related articles

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar RM, Brown D, Gilson RJ, Tedder RJ, Dusheiko GM, Jacobs M, Klenerman P, Maini MK.

Gastroenterology. 2009 Oct;137(4):1289-300. Epub 2009 Jul 7.PMID: 19591831 [PubMed - indexed for MEDLINE]Related articles

Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study.

Bansi L, Turner J, Gilson R, Post F, Gazzard B, Leen C, Anderson J, Porter K, Hill T, Fisher M, Ainsworth J, Pillay D, Johnson M, Winston A, Orkin C, Easterbrook P, Phillips A, Sabin C; UK Collaborative HIV Cohort Study.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):391-6.PMID: 19553826 [PubMed - indexed for MEDLINE]Related articles

CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.

Bower M, Fisher M, Hill T, Reeves I, Walsh J, Orkin C, Phillips AN, Bansi L, Gilson R, Easterbrook P, Johnson M, Gazzard B, Leen C, Pillay D, Schwenk A, Anderson J, Porter K, Gompels M, Sabin CA; UK CHIC Steering Committee.

Haematologica. 2009 Jun;94(6):875-80. Epub 2009 Mar 31.PMID: 19336735 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study.

United Kingdom Collaborative HIV Cohort Study, Lee KJ, Dunn D, Gilson R, Porter K, Bansi L, Hill T, Phillips AN, Sabin CA, Schwenk A, Leen C, Delpech V, Anderson J, Gazzard B, Johnson M, Easterbrook P, Walsh J, Fisher M, Orkin C.

AIDS. 2008 Oct 1;22(15):1943-50.PMID: 18784458 [PubMed - indexed for MEDLINE]Related articles

Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.

Stöhr W, Back D, Dunn D, Sabin C, Winston A, Gilson R, Pillay D, Hill T, Ainsworth J, Pozniak A, Leen C, Bansi L, Fisher M, Orkin C, Anderson J, Johnson M, Easterbrook P, Gibbons S, Khoo S; Liverpool TDM Database; UK CHIC Study.

Antivir Ther. 2008;13(5):675-85.PMID: 18771051 [PubMed - indexed for MEDLINE]Related articles

Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection.

Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A, Maini MK.

J Clin Invest. 2008 May;118(5):1835-45.PMID: 18398508 [PubMed - indexed for MEDLINE]Related articlesFree article

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

Bansi LK, Benzie AA, Phillips AN, Portsmouth S, Hill T, Leen C, Schwenk A, Johnson M, Anderson J, Gilson R, Easterbrook P, Gazzard B, Fisher M, Orkin C, Porter K, Pillay D, Taylor GP, Walsh JC, Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study.

AIDS. 2008 Jan 30;22(3):349-56.PMID: 18195561 [PubMed - indexed for MEDLINE]Related articles

Survival following HIV infection of a cohort followed up from seroconversion in the UK.

Ewings FM, Bhaskaran K, McLean K, Hawkins D, Fisher M, Fidler S, Gilson R, Nock D, Brettle R, Johnson M, Phillips A, Porter K; UK Register of HIV Seroconverters.

AIDS. 2008 Jan 2;22(1):89-95.PMID: 18090396 [PubMed - indexed for MEDLINE]Related articles

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.

Phillips AN, Leen C, Wilson A, Anderson J, Dunn D, Schwenk A, Orkin C, Hill T, Fisher M, Walsh J, Pillay D, Bansi L, Gazzard B, Easterbrook P, Gilson R, Johnson M, Sabin CA; UK Collaborative HIV Cohort (CHIC) Study.

Lancet. 2007 Dec 8;370(9603):1923-8.PMID: 18068516 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Cooksley H, Chokshi S, Maayan Y, Wedemeyer H, Andreone P, Gilson R, Warnes T, Paganin S, Zoulim F, Frederick D, Neumann AU, Brosgart CL, Naoumov NV.

Antimicrob Agents Chemother. 2008 Jan;52(1):312-20. Epub 2007 Nov 5.PMID: 17984230 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.

Porter K, Walker S, Hill T, Anderson J, Leen C, Johnson M, Gazzard B, Walsh J, Fisher M, Orkin C, Schwenk A, Gilson R, Easterbrook P, Delpech V, Sabin CA; UK CHIC Study Group.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):202-5.PMID: 17971709 [PubMed - indexed for MEDLINE]Related articles

Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.

Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.

J Med Virol. 2007 Oct;79(10):1464-71.PMID: 17705185 [PubMed - indexed for MEDLINE]Related articles

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count.

Phillips AN, Gazzard B, Gilson R, Easterbrook P, Johnson M, Walsh J, Leen C, Fisher M, Orkin C, Anderson J, Pillay D, Delpech V, Sabin C, Schwenk A, Dunn D, Gompels M, Hill T, Porter K, Babiker A; UK Collaborative HIV Cohort Study.

AIDS. 2007 Aug 20;21(13):1717-21.PMID: 17690569 [PubMed - indexed for MEDLINE]Related articles

Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures.

Benzie AA, Bansi LK, Sabin CA, Portsmouth S, Hill T, Johnson M, Gilson R, Easterbrook P, Gazzard B, Fisher M, Orkin C, Dunn D, Delpech V, Taylor GP, Walsh JC, Phillips AN; United Kingdom Collaborative HIV Cohort (CHIC) Study Group.

AIDS. 2007 Jul 11;21(11):1423-30.PMID: 17589188 [PubMed - indexed for MEDLINE]Related articles

Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.

Ferns RB, Naoumov NV, Gilson RJ, Tedder RS.

J Clin Virol. 2007 Jul;39(3):199-204. Epub 2007 May 29.PMID: 17526429 [PubMed - indexed for MEDLINE]Related articles

The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.

Smith CJ, Phillips AN, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G, Johnson MA, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group.

J Infect Dis. 2005 Oct 15;192(8):1387-97. Epub 2005 Sep 14.PMID: 16170756 [PubMed - indexed for MEDLINE]Related articles

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

Phillips AN, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti AM, Clarke J, Churchill D, Williams I, Hill T, Green H, Porter K, Scullard G, Johnson M, Easterbrook P, Gilson R, Fisher M, Loveday C, Gazzard B, Pillay D; UK Collaborative Group on HIV Drug Resistance; UK CHIC Study Group.

AIDS. 2005 Mar 25;19(5):487-94.PMID: 15764854 [PubMed - indexed for MEDLINE]Related articles